Liver fatty acid binding protein (L-FABP) is the principal target protein of the hepatic carcinogen N-(2-fluorenyl)acetamide (2-acetylaminofluorene) in rat liver. In addition, the cyclopentenone prostaglandins (PG), PGA, PGJ2, and A'2-PGJ2, inhibit the growth of many cell types in vitro. This report describes the preferential binding of the growth inhibitory prostaglandins by L-FABP and the reversible inhibition of thymidine incorporation into DNA by PGA2 and A'2-PGJ2 in primary cultures of purified rat hepatocytes. As a model ligand, [3HJPGAI bound to L-FABP specifically, reversibly, rapidly, and with high affinity. Its dissociation constants were 134 nM (high aftmity) and 3.6 ,uM (low affiity). Early events during chemical carcinogenesis usually involve a growth inhibition that in effect localizes the proliferation of chemically transformed cells to regions of focal hyperplasia surrounded by growth-suppressed nontransformed cells (1). The liver carcinogen N-(2-fluorenyl)acetamide (2-acetylaminofluorene, FAA) is especially effective in bringing about such growth inhibition and is used for that purpose in the resistant cell model of Solt and Farber for the rapid induction of focal hyperplasia in rat liver (1). Liver fatty acid binding protein (L-FABP), generally considered to be an intracellular carrier offatty acids (2-4), is the principal early target protein of the reactive metabolites of FAA in rat liver (5, 6). L-FABP is also a minor target of the liver carcinogenic aminoazo dyes (7). The marked specificity of L-FABP as the target protein of the FAA metabolites in vivo and the exceptional ability of FAA as a growth inhibitor raised the possibility of a direct association between L-FABP and the growth inhibition of hepatocytes. This connection is further supported by the recent finding that L-FABP is also a principal target protein of selenium in mouse liver (8). Selenium compounds reversibly block cell multiplication in cultures, inhibit carcinogenesis in animals, and correlate with lower cancer mortality rates in humans (reviewed in refs. 9 and 10
rather than inhibit DNA synthesis in rat hepatocytes in primary culture. The in vitro actions of L-FABP are compatible with those of a specific and dissociable carrier of growth inhibitory prostaglandins in rat hepatocytes and suggest that the carcinogen may usurp the cellular machinery of the growth inhibitory prostaglandins.
Early events during chemical carcinogenesis usually involve a growth inhibition that in effect localizes the proliferation of chemically transformed cells to regions of focal hyperplasia surrounded by growth-suppressed nontransformed cells (1) . The liver carcinogen N-(2-fluorenyl)acetamide (2-acetylaminofluorene, FAA) is especially effective in bringing about such growth inhibition and is used for that purpose in the resistant cell model of Solt and Farber for the rapid induction of focal hyperplasia in rat liver (1) . Liver fatty acid binding protein (L-FABP), generally considered to be an intracellular carrier offatty acids (2) (3) (4) , is the principal early target protein of the reactive metabolites of FAA in rat liver (5, 6) . L-FABP is also a minor target of the liver carcinogenic aminoazo dyes (7) . The marked specificity of L-FABP as the target protein of the FAA metabolites in vivo and the exceptional ability of FAA as a growth inhibitor raised the possibility of a direct association between L-FABP and the growth inhibition of hepatocytes. This connection is further supported by the recent finding that L-FABP is also a principal target protein of selenium in mouse liver (8) . Selenium compounds reversibly block cell multiplication in cultures, inhibit carcinogenesis in animals, and correlate with lower cancer mortality rates in humans (reviewed in refs. 9 and 10). In addition, L-FABP belongs to a protein family (11) in which five members are linked to the depression of cell multiplication (see Discussion).
Prostaglandins are local tissue hormones (12, 13) . In liver, they are produced mainly by Kupffer and endothelial cells and appear to act on adjacent hepatocytes (14, 15) . The predominant prostanoid synthesized by these nonparenchymal cells is prostaglandin D2 (PGD2) (14) , which is converted spontaneously and catalytically to PGJ2 and then to A'2-PGJ2 (16, 17) . PGEs undergo similar reactions in the formation of PGAs (16) . These products (PGJ2, A12-PGJ2, PGA1, and PGA2) inhibit cell growth and do so apparently by virtue of their a,,3-unsaturated double bonds adjacent to keto groups in their cyclopentenone ring (ref. 18 , reviewed in ref. 19 ). Such double bonds react with protein thiols and glutathione (20, 21) . A12-PGJ2 contains two such double bonds, whereas PGJ2 and the PGAs each have one. Several groups have reported that these cyclopentenone prostaglandins suppress the growth of many types of human and animal tumor cell lines in vitro and in vivo and normal mouse fibroblasts and smooth muscle cells in culture (reviewed in ref. 19 ). To our knowledge, effects of these prostaglandins on primary cultured hepatocytes have not been described. These prostaglandins have been found to be actively taken up by various cells, in which they migrate in part to nuclei apparently by a ligand-selective and carrier-mediated process that correlates with growth inhibitory activity and its reversibility (22) (23) (24) . In comparison, PGD2 and PGEs exhibit lower growth inhibitory activities, in part attributed to their gradual conversion to the cyclopentenone prostaglandins (18, 25, 26) . In contrast, PGF2a and PGE2 itself have been reported to stimulate DNA synthesis in primary cultures of adult rat hepatocytes (27) .
We demonstrate here that the growth inhibitory cyclopentenone prostaglandins preferentially bind to L-FABP in vitro and reversibly suppress incorporation ofthymidine into DNA in normal rat hepatocytes in primary culture. The rank order of the binding of the different prostaglandins to L-FABP is in accord with their relative growth inhibitory activities. The evidence suggests that L-FABP may be a preferential and dissociable carrier of the growth inhibitory cyclopentenone prostaglandins in normal rat hepatocytes.
MATERIALS AND METHODS
Materials. [5,6( *To whom reprint requests should be addressed.
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were likewise divided and maintained. Lipidex-1000 (Packard Instrument) was kept at 40C in methanol until used.
Ligand Binding. L-FABP of high purity according to SDS/ polyacrylamide gel electrophoresis was previously prepared, characterized in part, and stored in 10 mM potassium phosphate buffer (pH 7.5) at -60'C (28) . Binding to L-FABP was measured essentially as reported (28) (see Fig. 1 and Tables  2 and 3) .
Hepatocyte Cultures. Hepatocytes of 1-4 normal male rats (249-333 g) of the in-house-bred F344-NIH strain were isolated by differential centrifugation after perfusion with collagenase (type IV, Sigma) at 370C (29) A12-PGJ2 also inhibited DNA synthesis in rat hepatocytes. The IC50 was between 2.5 and 5.0 ,ug/ml (7.5-15 ,uM) ( Table  1 ). Higher concentrations were cytotoxic. The inhibitions brought about in the narrow range of 0.5-1.0 ,g/ml were in part reversible (Table 1) . However, exposure to A12-PGJ2, combined with serum-free conditions for two 6-hr periods, brought about effects bordering on significant loss of viability. PGJ2 (0.63-40 ,ug/ml; i.e., =2-120 ,uM) and PGD2 (1.25-40 ug/ml; i.e., 3.5-114 ,uM) also inhibited thymidine incorporation in initial experiments (data not shown). High-Affinity Binding of PGA1. Two classes of PGA1 binding sites were present in L-FABP (Fig. 2) , as revealed by Scatchard analysis (31). Below 1.0 nmol of total PGA1, high-affinity sites with a dissociation constant (Kd) of 134 nM bound up to 0.65 nmol of PGA1 per nmol of L-FABP. At the higher concentrations, low-affinity sites with a Kd of 3.6 A.M bound up to 2.8 nmol of ligand per nmol of protein (extrapolated). The high-affinity binding of PGA1 was 9-fold more avid than with oleic acid (Kd = 1.2 tkM) (28) and almost 13-fold more avid than with arachidonic acid (Kd = 1.7 gM) (28) . In fact, it was the low-affinity Kd of PGA1 that was comparable to the reported Kd values of these and other fatty acids (2-4).
Proc. Natl. Acad Sci. USA 87 (1990) ligand). Bovine serum albumin had significantly less activity (0.14 nmol; 35%). The other proteins, f8-lactoglobulin, ribonuclease, and ovalbumin, exhibited low or insignificant binding. In addition, after binding to each protein, the mixtures were exposed to a 10-fold excess of unlabeled PGA1 in displacement assays. One-half of the [3H]PGA1 bound to L-FABP was displaced by the 10-fold PGA1, compared to 21% with bovine serum albumin and essentially none with the others. L-FABP thus bound the most ligand, and its binding was the most dissociable and presumably noncovalent.
DISCUSSION
Growth of hepatocytes may be subject to paracrinal influences. Fewer than 1 in 1500 hepatocytes divide at any time in adult rat liver (32) . Kupffer and endothelial cells, located adjacent to hepatocytes, produce relatively large amounts of PGD2 and PGE2 (14, 15) , which spontaneously and catalytically convert to the growth inhibitors PGJ2, A12-PGJ2, and PGA2 (16-18, 22, 23) . In apparent accord, PGA2 and A'12-PGJ2 suppressed thymidine incorporation into DNA of purified normal rat hepatocytes in culture.
That micromolar concentrations of PGA2 and A12-PGJ2 inhibited DNA synthesis is striking evidence of their sequestration in hepatocytes. Free cyclopentenone prostaglandins Fig. 1 and Table 2 ). Values are corrected for assays without L-FABP. NS, not significant.
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Cell Biology: Khan and Sorof can react with glutathione without and with the catalytic aid ofglutathione S-transferases (20, 21, 33, 34) . Since normal rat liver contains a high concentration (-10 mM) of glutathione (35) and the transferases may constitute as much as 10% of all cytosolic proteins of normal rat liver (33), any free cyclopentenone prostaglandin would be consumed. Instead, A12-PGJ2 is incorporated into cells, where they migrate to nuclei and fix irreversibly to nucleoproteins (22) (23) (24) . PGA2 localizes more in cytoplasm, where the prostaglandin can be eliminated by removal from the culture medium (22) (23) (24) . Importantly, the cyclopentenone prostaglandins inhibit the growth of several cell lines through a block at the G1 phase near the G1/S interface in the cell cycle (36) (37) (38) . In agreement, inhibition of DNA synthesis by PGA1 and PGA2 is not due to a depression of thymidine uptake in cultured melanoma cells (39) , and in cultured hepatocytes it is not the result of either a lowered rate of cell entry of thymidine or an increase in intracellular pool size of thymidine nucleotide (this report). Considering these findings, as well as the specific and reversible high affinity binding of PGA1 and the preferential binding of the inhibitory prostaglandins by L-FABP (below), the evidence suggests that L-FABP may act as a carrier of growth inhibitory prostaglandins in rat hepatocytes.
The cyclopentenone prostaglandins were preferentially bound by L-FABP. The potent growth inhibitory cyclopentenone prostaglandins, PGA1, PGA2, A'2-PGJ2 and PGJ2, competed maximally with the high-affinity binding of [3H]PGA1. Next in decreasing order were oleic acid and PGE1, and last were PGD2, PGF2a and PGE2. Dutta-Roy et al. reported previously that PGE1 binds to L-FABP in a specific manner but with an affinity that was observed in the presence of 3 mM MgCI2 (40) . A correlation thus exists between the relative affinities of the different prostaglandins for L-FABP and their growth inhibitory activities. The cyclopentenone prostaglandins, which potently inhibit DNA synthesis and cell multiplication (refs. 18, 19, 22-24; this report), bind preferentially. Next, PGE1 and PGD2 are intermediate competitors. In agreement, A12-PGJ2 is 7-to 17-fold and PGA and PGJ2 are 3-to 7-fold more growth inhibitory than are PGE1 and PGD2 (19) , both of which are converted gradually to the growth inhibitory prostaglandins (18, 19, (22) (23) (24) . Finally, the two poorest competitors were PGE2 and PGF2a, which are actually reported to stimulate DNA synthesis in primary cultures of adult rat hepatocytes (27) .
The ligand-binding site(s) of L-FABP apparently binds the growth inhibitory cyclopentenone prostaglandins both noncovalently and covalently. The competitive binding between PGA1 and oleic acid, and that previously reported between 15-hydroperoxyeicosatetraenoic acid (15-HPETE) and oleic acid (28) , indicates that these ligands bind at or near the same site in L-FABP. However, the binding of PGA1 by L-FABP differed from those of fatty acids (2) (3) (4) 28) , (28) , and 15-hydroxyeicosatetraenoic acid (15-HETE) (28) . Whereas the molar ratios ofthe latter group of ligands relative to L-FABP were 1 or 2 (2) (3) (4) 28) , the molar ratio of PGA1 reached -3. PGAs, PGJ2, and A12-PGJ2 can interact with protein thiols (20) , and L-FABP contains only one cysteine residue, which is situated midway in the molecule (41) . Nevertheless, the following data suggest that the high-affinity binding of the first PGA1 molecule is noncovalent in nature. First, the high-affinity Kd value of PGA1 at 134 nM is similar in magnitude to those of other nonreactive, high-affinity eicosanoid ligands of L-FABP, namely 15-HPETE (76 nM) and 5-HETE (175 nM) (28) . Second, it was the low-affinity binding at elevated concentrations of PGA1 that extrapolated to a molar ratio of -3 in the Scatchard plot (Fig. 2) (15) (each at -0.5 ,uM). Thus, there appears to be ample concentrations of the precursors of the cyclopentenone prostaglandins in rat liver. It is also noteworthy that A12-PGJ2 is present in human urine, indicative that that prostaglandin is a natural metabolite (43) . Furthermore, the reported existence of cellular machinery for their specific uptake and carrier-mediated nuclear localizations, both of which correlate with growth inhibitory activities (22) (23) (24) (2) (3) (4) , which conceivably may act similarly.
L-FABP belongs to a family of proteins whose genes share homology in their first exons (11) . In the family are five proteins that appear to be connected with depression of cell multiplication in six biological systems. First, L-FABP itself is the target protein of the reactive metabolites of the hepatocarcinogens FAA (5, 6) and aminoazo dyes (7) in vivo. Early effects of these and other carcinogens involve growth inhibition of target cells (Introduction). Second, L-FABP is a principal target protein of selenium in mouse liver (8) . Selenium compounds reversibly block cell multiplication in cultured cells (9, 10) . Third and fourth, cellular retinol binding protein I and cellular retinoic acid binding protein, which appear to be intracellular carriers of retinol and retinoic acid, respectively, are associated with the cessation of cell multiplication that accompanies cellular differentiation (reviewed in refs. 44 and 45) . Fifth, the potent mammaryderived growth inhibitory protein from bovine lactating (nongrowing) mammary glands reversibly suppresses cell multiplication and thymidine incorporation in a variety of epithelial cells (46) . Sixth, the fibroblast growth regulator-soluble, a protein that is secreted by growth-inhibited NIH 3T3 cells at confluence, reversibly blocks DNA synthesis and cell replication at 0.1 nM in a variety of fibroblast lines (47, 48) . Collectively, these different systems support the present finding of a link between L-FABP and inhibition of cell multiplication.
The preferential binding of the growth inhibitory cyclopentenone prostaglandins by L-FABP in vitro may be related to the specific covalent binding of the reactive metabolites of FAA carcinogen to that same protein during hepatocarcinogenesis in rats (5, 6) . The actions of L-FABP as the common and specific target of both types of ligands suggest the possibility that the reactive metabolites of the carcinogen may usurp the cellular machinery of the growth inhibitory prostaglandins in rat hepatocytes in a process important in carcinogenesis.
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